The ELANE gene gives instructions for making neutrophil elastase, a protein in infection-fighting white blood cells that helps break down germs. If this gene does not work properly, your body may make too few neutrophils, which can lead to repeated infections, fevers, and mouth sores. This gene plays an important role in early white blood cell development, and some ELANE variants are linked to cyclic neutropenia or severe congenital neutropenia. ELANE is mainly discussed in medical genetics and family testing rather than in popular culture.
What is a gene?
A gene is a piece of DNA that carries instructions your cells use to make molecules or regulate processes in the body. Some genes contain the code for making proteins, the working parts of cells. Other genes mainly control when certain processes happen, where they take place, and how strongly they operate. Together, genes affect how the body develops and functions, and they can also shape how you respond to food, stress, or medications. To explore this topic in more detail, you can read more in the LearnHub.
Overview
ELANEGene function
What if the gene works
The ELANE gene helps make neutrophil elastase, a protein in white blood cells that fight infection. It helps break down germs and damaged proteins during inflammation and supports normal immune defense.
Risk
What if the gene does not work
Variants in the ELANE gene can disrupt neutrophil elastase, leading to cyclic neutropenia or severe congenital neutropenia. Milder and more severe variants may influence when low neutrophil counts begin and how often infections occur.
Treatment
What does that mean for your treatment
Pathogenic variants in the ELANE gene often make long term treatment with G-CSF, such as filgrastim, part of care to raise neutrophil counts and reduce infections. If counts stay low or very high doses are needed, care may shift toward a blood stem cell transplant.
Conditions associated with ELANE
Gene function
What if the gene works
ELANE helps certain white blood cells called neutrophils respond when germs enter the body. It provides instructions for neutrophil elastase, an enzyme that cuts proteins into smaller pieces and is kept ready inside these cells. This is a key part of what the ELANE gene does in the immune system.
The ELANE gene gives neutrophils instructions to make neutrophil elastase, an enzyme that cuts proteins into smaller pieces. This cutting action helps the cell handle proteins from germs and from material that needs clearing away.
Neutrophils store this enzyme in small packets until they meet bacteria or fungi. When released in a controlled way, it helps these white blood cells damage and break down invading microbes.
Neutrophil elastase also helps trim proteins at sites of inflammation. This supports early immune cleanup and can help tissues return to a more settled state after the first response.
What is a variant?
A genetic variant is a minor difference in a gene’s DNA sequence. These differences are common and are part of normal human diversity, including variation in appearance, metabolism, and the way the body responds to environmental influences. Many variants do not lead to any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant changes how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Many ELANE gene variants change the shape of neutrophil elastase, so the protein may fold poorly, get trapped inside developing white blood cells, or interfere with normal cell processing. In practical terms, this is how ELANE gene variants affect protein function. Some variants leave partial function, while more disruptive variants create stronger cell stress and can be linked to earlier or more persistent neutropenia.
How variants are linked to conditions
Pathogenic variants in the ELANE gene can cause cyclic neutropenia or severe congenital neutropenia, two inherited conditions marked by repeated low neutrophil counts and frequent infections. In practice, ELANE gene variants linked to cyclic neutropenia and severe congenital neutropenia can confirm the diagnosis when they match a person’s symptoms and blood test pattern. People with ELANE-related severe congenital neutropenia may also have a higher long-term risk of myelodysplastic syndrome or acute myeloid leukemia.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are widely found in the general population. Most do not directly affect health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a certain diagnosis, especially when more than one gene and environmental factors contribute. In some situations, though, a single well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For ELANE, risk is mostly shaped by the specific gene change, because some changes are linked to milder cyclic drops in infection-fighting cells while others cause more severe, ongoing low levels. In severe forms, poor response to treatment and extra gene changes that develop in bone marrow cells can raise the chance of serious complications, so regular monitoring is important.
Inheritance of ELANE variants
ELANE-related conditions such as cyclic neutropenia and severe congenital neutropenia are usually inherited in an autosomal dominant pattern. This means a parent carrying an ELANE gene variant can pass it to a child with a 50% chance in each pregnancy, whether the child is a son or a daughter. In some families, understanding how ELANE gene variants are inherited also includes the fact that a child can have a new, de novo variant that was not inherited from either parent. Once present, that variant can then be passed on in the same autosomal dominant way.
What does my ELANE result mean for my family?
ELANE-related low white blood cell conditions usually run in families in a dominant pattern, so close relatives such as parents, brothers, sisters, and children may also carry the same gene change and may want to learn whether they have it. In some families, a child has a new ELANE change that was not inherited from either parent, so a positive result does not always mean a parent has it too. The exact health effects can vary, even within the same family.
Genetic information
Genetic testing
How you find out about variants
To look for variants, ELANE genetic testing uses a blood or saliva sample to read the ELANE gene. A lab checks the DNA sequence for changes and compares any variant with known benign or disease causing patterns. Results can confirm an inherited cause of some neutropenia types or identify a variant that needs careful interpretation.
When should I consider getting a genetic test?
Consider testing for the ELANE gene if you or your child has repeated serious infections, frequent mouth sores or fevers, and very low levels of infection-fighting white blood cells, especially if this happens in cycles or runs in the family. An ELANE test can help confirm an inherited cause.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it explains depends on the condition and the type of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, influence how the body functions. For some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body handles medicines, including how quickly a drug is broken down, how strongly it works, or how likely side effects are. This helps explain why the same medication may help one person a lot, help another only a little, or feel too strong at a usual dose. These differences are common and are one reason treatment response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics is the area of study that examines how genetic differences affect the way people respond to medications. It focuses on links between genes and drugs to help explain why the same treatment can work differently from one person to another. With many medicines, genes can influence how powerfully a drug works or how the body handles it. This information can support treatment choices that are better informed and more individualized. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the ELANE gene
When should I seek medical advice?
There isn't yet a broadly confirmed role for this gene in predicting medication response, so questions about medicines, side effects, or treatment changes are best discussed with your doctor.
History
Throughout history, people have described repeated infections and mouth sores in families long before the cause was clear. Early reports of cyclic neutropenia and severe congenital neutropenia led doctors to suspect an inherited pattern. Initially understood only through visible traits, later recognized as tied to a specific gene, this condition became clearer as blood testing improved in the 20th century. In the late 1990s, researchers linked many cases to variants in the ELANE gene, which was then commonly called ELA2. From these first observations, research expanded steadily, helping connect family histories with a specific genetic finding. Scientific classifications changed as researchers learned more about the gene, and ELANE is now a well established part of the history of inherited neutropenia.